-+ 0.00%
-+ 0.00%
-+ 0.00%

Clover Health releases transcript of 2Q26 supplemental Q&A on earnings call

PUBT·08/20/2026 20:34:51
Listen to the news
Clover Health releases transcript of 2Q26 supplemental Q&A on earnings call
  • Clover Health posted a 2Q26 supplemental shareholder Q&A transcript featuring remarks from CEO Andrew Toy.
  • Cohort maturation under Clover Assistant cited as key driver, with year-3 members generating about $155 PMPM more insurance gross profit than year-1.
  • Year-3 Clover Assistant-managed cohort showed an MCR about 18% better than non-assisted members, framed as compounding economics over time.
  • CMS rated Clover’s PPO and HMO plans at 4.5 Stars for the 2027 payment year; management said it is operating on that basis.
  • Counterpart Health positioned to prioritize lives under management and demonstrated impact before material financial contribution, with “real-time value-based payment” models under consideration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Health Investments Corp. published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.